Alexander Nolte - Net Worth and Insider Trading
Alexander Nolte Net Worth
The estimated net worth of Alexander Nolte is at least $0 dollars as of 2025-07-23. Alexander Nolte is the Chief Accounting Officer of Syndax Pharmaceuticals Inc and owns about 0 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $0. Details can be seen in Alexander Nolte's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexander Nolte has not made any transactions after 2022-02-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alexander Nolte
Alexander Nolte Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander Nolte owns 2 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , and Oncorus Inc (ONCR) .
Click here to see the complete history of Alexander Nolte’s form 4 insider trades.
Insider Ownership Summary of Alexander Nolte
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2022-02-01 | Chief Accounting Officer |
| ONCR | Oncorus Inc | 2023-05-09 | Interim CFO |
Alexander Nolte Latest Holdings Summary
Alexander Nolte currently owns a total of 1 stock. Alexander Nolte owns 0 shares of Syndax Pharmaceuticals Inc (SNDX) as of February 1, 2022, with a value of $0.
Latest Holdings of Alexander Nolte
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2022-02-01 | 0 | 10.31 | 0 |
Holding Weightings of Alexander Nolte
Alexander Nolte Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander Nolte has made a total of 1 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 968 shares on February 1, 2022, which brought Alexander Nolte around $16,117.
Insider Trading History of Alexander Nolte
- 1
Alexander Nolte Trading Performance
Alexander Nolte Ownership Network
Ownership Network List of Alexander Nolte
Ownership Network Relation of Alexander Nolte
Alexander Nolte Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Alexander Nolte is the Chief Accounting Officer of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include President and COO Michael A Metzger , Chief Financial Officer Keith A. Goldan , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Alexander Nolte made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 28,636 shares made by Michael A Metzger , a net sale of 3,823 shares made by Keith A. Goldan , and a net purchase of 11,765 shares made by .
In summary, during the past 3 months, insiders sold 8,830 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 26,765 shares, with a net purchase of 17,935 shares. During the past 18 months, 38,327 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 28,015 shares were bought by its insiders, resulting in a net sale of 10,312 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Alexander Nolte Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander Nolte. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alexander Nolte's mailing address is: Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
